HIGH THROUGHPUT METHODS FOR VIRUS QUANTIFICATION
    124.
    发明申请
    HIGH THROUGHPUT METHODS FOR VIRUS QUANTIFICATION 审中-公开
    用于病毒量化的高通量方法

    公开(公告)号:US20170023570A1

    公开(公告)日:2017-01-26

    申请号:US15215106

    申请日:2016-07-20

    Applicant: MERIAL INC.

    Inventor: Jean Reyes

    Abstract: This invention relates to high throughput methods of determining a viral titer. The instant invention addresses the need for a more rapid and cost effective method of quantitating infectious viral particles in a sample.

    Abstract translation: 本发明涉及确定病毒滴度的高通量方法。 本发明解决了对样品中感染性病毒颗粒进行定量的更快速和成本有效的方法的需要。

    Her2 DNA Vaccine as Adjunct Treatment for Cancers in Companion Animals
    129.
    发明申请
    Her2 DNA Vaccine as Adjunct Treatment for Cancers in Companion Animals 有权
    Her2 DNA疫苗作为伴侣动物癌症的辅助治疗

    公开(公告)号:US20150374808A1

    公开(公告)日:2015-12-31

    申请号:US14699296

    申请日:2015-04-29

    Applicant: MERIAL INC.

    CPC classification number: A61K39/0011 A61K48/00 A61K2039/53 A61K2039/545

    Abstract: The application discloses therapeutic vaccines based upon the “pING” DNA plasmid vector expressing the gene encoding the rat Her2 protein. Vaccines according to the instant disclosure are used as an adjunct treatment for surgery, radiation and/or chemotherapy for dogs and cats with cancers that over express the Her2 antigen, and prolong the post-surgical disease free interval and/or survival time. Also included are therapeutically effective methods of immunization using said vaccines.

    Abstract translation: 该申请公开了基于表达编码大鼠Her2蛋白的基因的“pING”DNA质粒载体的治疗性疫苗。 根据本公开的疫苗被用作用于具有过表达Her2抗原的癌症的狗和猫的手术,放射和/或化学疗法的辅助治疗,并且延长了手术后无疾病间隔和/或存活时间。 还包括使用所述疫苗的治疗有效的免疫方法。

Patent Agency Ranking